Filters
Other countries
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
TSPYL1 Gene Sudden infant death with dysgenesis of the testes syndrome NGS Genetic DNA Test DNA Labs India India | 1 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 243 | 238 |
|
TSPYL1 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 1 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 829 | 848 |
|
Invitae Disorders of Sex Development Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 88 | 53 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
PreventionGenetics, part of Exact Sciences United States | 128 | 85 |
|
Differences of Sex Development (DSD) Panel PreventionGenetics, part of Exact Sciences United States | 149 | 158 |
|
Differences of Sex Development (DSD) and Infertility Panel PreventionGenetics, part of Exact Sciences United States | 223 | 238 |
|
qGenEx Sex development disorders Quantitative Genomic Medicine Laboratories, SL Spain | 45 | 48 |
|
Diseases of sexual development (WES based NGS panel of 46 genes, including CNV analysis) CGC Genetics Unilabs Portugal | 1 | 46 |
|
Genomic Unity® Custom Analysis Variantyx, Inc. United States | 1 | 4054 |
|
Custom XomeDx Slice – Differences of Sex Development (Proband Only) GeneDx United States | 21 | 112 |
|
Prenatal Known Familial Mutation GeneDx United States | 1 | 1716 |
|
Custom XomeDxSlice (2-150 Genes, Proband Only) GeneDx United States | 1 | 1718 |
|
Abnormal/Ambiguous Genitalia Panel Genetic Services Laboratory University of Chicago United States | 81 | 92 |
|
46,XY Disorders of Sex Development/Complete Gonadal Dysgenesis Panel Genetic Services Laboratory University of Chicago United States | 27 | 33 |
|
Fulgent Genetics United States | 1 | 1 |
|
Fulgent Genetics United States | 5128 | 4672 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.